Patients Claim Allergan Covered Up Risks Of Breast Implants

Law360 (August 28, 2019, 4:43 PM EDT) -- Allergan Inc. used regulatory loopholes to conceal a strong link between its textured silicone breast implants and a rare form of cancer and is now refusing to pay for surgery to remove the implants following a massive recall, according to a new proposed class action.

In Tuesday's 26-page complaint in California federal court, anonymous female plaintiffs A.B. and C.D. said they've both fallen victim to that rare form of immune system cancer, breast-implant-associated anaplastic large-cell lymphoma, or BIA-ALCL, and are now faced with paying out of pocket to remove the Allergan Biocell textured implants that likely caused it.

The women said...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS